Vascular characterisation of triple negative breast carcinomas using dynamic MRI

Eur Radiol. 2011 Jul;21(7):1364-73. doi: 10.1007/s00330-011-2061-2. Epub 2011 Jan 22.

Abstract

Objectives: Triple-negative (ER-/PR-/HER2-) breast carcinomas (TNBC) are aggressive tumours with underexplored imaging features. This study investigates whether their vascular characteristics as assessed by dynamic contrast-enhanced (DCE) and dynamic susceptibility contrast-enhanced (DSC) MRI are distinct from the prognostically more favourable ER+/PR+/HER2- cancers.

Methods: Patients with primary breast cancer underwent MRI before neoadjuvant chemotherapy and were identified as ER-/PR-/HER2- or ER+/PR+/HER2- from core biopsy specimens. MRI parameters reflecting tissue perfusion, permeability, and extracellular leakage space were measured. Values for inflow transfer constant (K(trans)), outflow rate constant (k(ep)), leakage space (v(e)), area under the gadolinium curve (IAUGC(60) ), relative blood volume (rBV) and flow (rBF), and Mean Transit Time (MTT) were compared across receptor status and with known prognostic variables.

Results: Thirty seven patients were assessable in total (16 ER-/PR-/HER2-, 21 ER+/PR+/HER2-). Lower v(e) (p = 0.001), shorter MTT (p = 0.007) and higher k(ep) values (p = 0.044) were observed in TNBC. v(e) was lower across all T stages, node-negative (p = 0.004) and low-grade TNBC (p = 0.037). v(e) was the best predictor of triple negativity (ROC AUC 0.80).

Conclusions: TNBC possess characteristic features on imaging, with lower extracellular space (higher cell density) and higher contrast agent wash-out rate (higher vascular permeability) suggesting a distinctive phenotype detectable by MRI.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Aged
  • Area Under Curve
  • Biopsy, Needle
  • Blood Flow Velocity
  • Blood Volume
  • Breast Neoplasms / blood supply*
  • Breast Neoplasms / pathology
  • Contrast Media / pharmacokinetics
  • Female
  • Gadolinium DTPA / pharmacokinetics
  • Humans
  • In Situ Hybridization, Fluorescence
  • Magnetic Resonance Imaging / methods*
  • Middle Aged
  • Neoplasm Staging
  • Phenotype
  • Prognosis
  • ROC Curve
  • Receptor, ErbB-2 / analysis
  • Receptors, Estrogen / analysis
  • Receptors, Progesterone / analysis
  • Retrospective Studies
  • Statistics, Nonparametric

Substances

  • Contrast Media
  • Receptors, Estrogen
  • Receptors, Progesterone
  • Receptor, ErbB-2
  • Gadolinium DTPA